(NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity.

While the Straits Times Index and the Hang Seng Tech Index may be in corrective phases, the Nasdaq Composite and S&P 500 ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Last week marked a sell-off not seen since the pandemic-induced market crash of 2020. In just two days (Thursday and Friday), ...

US stocks pulled back on Tuesday, led by a nearly 2% decline in the Nasdaq, following two days ... Nvidia stock (NVDA) fell 3% at the market open on Tuesday ahead of the AI giant's GTC event ...

Indian markets ended the week sharply lower as President Trumps retaliatory tariffs sparked global selloffs and recession ...

One of those is Broadcom (NASDAQ: AVGO), as the market hasn't priced in the future growth of an exciting product line. At one ...

Price action: The daily chart shows the two previously available entry points on a ‘breakdown trade’ as ‘1’ and ‘2’. At this ...

Meisler focused on the Nasdaq this week since the index saw the steepest pullback of the three major indexes. The chart below shows overall market breadth, which tracks most stocks. It recently ...

Bitcoin bides its time above $80,000 as stocks fail to rally on low inflation and three-year US Dollar Index lows.

Dharmesh Shah suggests focusing on the domestic sector, with banking showing relative outperformance even in the current ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio ...